enVVeno Medical’s bold bioprosthetic devices for venous disease clash with a sharp stock decline—explore its innovation, volatility, and investor outlook.
Discover how Dian Diagnostics, a leading Chinese lab group, is expanding its genomic services through partnerships with Foundation Medicine and Roche, boosting market growth.
NURECA Limited sees promoter buy‑back, signalling confidence in its home‑healthcare portfolio and growth prospects. Read the insider move that could shape future strategy.
CVS Health’s latest moves—Aetna’s rapid profit turnaround, 20‑year Project Health screenings, and a women‑focused weight‑management program—boost investor confidence and set a new standard for community‑centric care.
Explore how Nasdaq‑listed FEMASYS INC is pioneering next‑generation biomedical solutions to fill underserved healthcare gaps, amid volatile stock and long‑term growth focus.
Perspectum Group PLC boosts biotech innovation by adding a patent‑pending QR‑code platform to Emmy gift bags, linking physical items to dynamic digital content.